Kendall Investor Relations was founded to provide a truly different investor relations approach - we are former biotech senior executives with decades of experience in R&D, corporate development, commercial operations, finance, and investor relations, serving fellow biotech executives. We understand science, value creation, and how investors assess biotech investment opportunities. Our background, coupled with our relationships and credibility in the biotech investment community enables us to provide thoughtful, effective IR service that maximizes long term value. Contact us at kendallir.com.
Company Details
- Employees
- 5
- Founded
- -
- Address
- 245 1st St, Cambridge,massachusetts,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kendallir.com
- Keywords
- investor relations, finance, biotechnology, communications, pharmaceuticals, R&D, commercialization.
- HQ
- Cambridge, Massachusetts
Kendall Investor Relations, Llc Questions
Kendall Investor Relations, Llc's website is kendallir.com
Kendall Investor Relations, Llc's LinkedIn profile is https://www.linkedin.com/company/kendallir
Kendall Investor Relations, Llc has
5 employees.
View email and phone details for 5
employees at Kendall Investor Relations, Llc.
Kendall Investor Relations, Llc's industry is
Biotechnology Research
Kendall Investor Relations, Llc's top competitors are
Cartesian Therapeutics,
Qr8 Health,
Precision Aq - Investor Relations & External Communications,
Seaport Therapeutics,
Lifesci Advisors, Llc,
Investor Relations Partners,
Allele Communications,
Attract Capital, Llc,
Argot Partners,
Gilmartin Group Llc.
Kendall Investor Relations, Llc's categories are Biotechnology Research
Kendall Investor Relations, Llc's founding year is 2018
